Yale Bulletin and Calendar

July 15, 2005|Volume 33, Number 31|Six-Week Issue


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Discovery of breast cancer growth regulator
may help measure treatment's effectiveness

Researchers at the School of Medicine have discovered the breast cancer growth regulator sEGFR, which may be a useful tool in monitoring a patient's responsiveness to treatment with the drug letrozole.

Published in a recent issue of the American Association of Cancer Researcher's journal Cancer Research, the study focused on how decreased concentrations of sEGFR can indicate the effectiveness of letrozole.

In women with postmenopausal breast cancer, the hormone estrogen often stimulates tumor growth. Letrozole, which is currently used in breast cancer therapy, stops the local production of estrogen, therefore reducing tumor growth. To monitor the effectiveness of this drug's reduction in tumor growth, estrogen levels are measured. In postmenopausal women with breast cancer, estrogen can be difficult to measure because the levels are already quite low.

The Yale team -- led by Dr. Nita J. Maihle, professor in the Department of Obstetrics, Gynecology & Reproductive Sciences -- discovered sEGFR, another regulator of breast cancer growth that can be used to measure responsiveness to treatment.

Maihle and her colleagues collected blood samples from postmenopausal women with metastatic breast cancer before treatment with letrozole, and then one month and three months after letrozole therapy. The team measured sEGFR concentrations in these blood samples and found that after one month of letrozole therapy, sEGFR decreased in 73% of patients and after three months of letrozole therapy, sEGFR concentrations decreased in 76% of patients when compared to pretreatment levels.

"Unfortunately, the number of patients (43) involved in this study was not large enough to evaluate how these changes in sEGFR levels predict a patient's cancer progression or survival," says Maihle. "Since the FDA recently approved letrozole for the treatment of breast cancer, larger studies are needed to determine its clinical utility."

"Ultimately, we hope to provide the most effective ways to determine who will respond to this new breast cancer therapy," adds Maihle, who is also affiliated with Yale Cancer Center.

Other authors on the study included Jacqueline M. Lafky, Andre T. Baron, Elsa M. Cora, David W. Hillman, Vera J. Suman, Edith A. Perez and James N. Ingle.

-- By Karen Peart


T H I SW E E K ' SS T O R I E S

Yale launches program to train urban teachers

New alumni fellow elected

Sensors won't save lives from suicide bombers, warns Yale expert

Study: Monkeys ape humans' economic traits

Richard Shaw departs for Stanford post

Tennis goes co-ed at this year's Pilot Pen

Yale co-sponsors 'City of Summer' concerts and films

Exhibit features post-Civil War works by 'artful storyteller'

Yale alumni, teachers win Tony Awards

ENDOWED PROFESSORSHIPS

Law School project exploring the information society . . .

Poll shows public's distaste with foreign oil dependence

Scientists discover how plants protect themselves from infection

Team seeking 'perfume' to control malaria-carrying mosquitoes

Geologists use ancient sea algae to trace CO2 levels of long ago

Study shows how sex discrimination in job hiring is able to endure

YSN study shows effectiveness of preschool health screenings

SCHOOL OF MEDICINE NEWS

Spotlight on Sports

Athletics archive now in library's collection

Three promoted to post of associate provost

Event to explore role of faith in the corporate world

In Memoriam: Dick Wittink, marketing expert and SOM teacher

Five faculty members awarded Guggenheim Fellowships for research

Event explored how libraries can benefit city schools

New alumni lauded for efforts to improve public schools

Yale Books in Brief

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home